We’re dedicated to delivering on the promise of targeted protein degradation (TPD) to create a new generation of medicines that transforms patients’ lives.

We have a leading scientific platform and remain disciplined in the targets we pursue. Through this focus, we have developed orally bioavailable small molecule degrader medicines that harness the body’s natural protein recycling system to rapidly degrade disease-causing proteins. We see the potential our TPD medicines have to drug disease-causing proteins, including those that are currently considered undruggable, and ultimately improve patient outcomes.